Accurate blood pressure (BP) measurement is dependent on a trained observer using validated and properly maintained equipment. BP devices should be checked regularly to ensure that their calibration remains within the European Standard specification of ± 3 mm Hg. This study assessed the air leakage rates and calibration accuracy of BP devices in use at a large teaching hospital, using a calibrated electronic pressure gauge as reference. Air leakage rates were recorded over 1 min and static pressures were recorded at 250/200/150/100/50/0 mm Hg for computer download and analysis. A total of 127 devices were assessed (18 mercury, 62 aneroid and 47 automated). In total, 22 different models of devices were available, of which 11 were automated and only 4 had published evidence of a validation using a recognized protocol (British Hypertension Society, Association for the Advancement of Medical Instrumentation or International Protocol). Only 3% (n ¼ 4) of devices had an air leakage rate within 4 mm Hg per min and 25% (n ¼ 32) of devices failed to meet the European calibration standard of ± 3 mm Hg. Respective failure rates were 6% (1/18) for mercury, 31% (19/62) for aneroid and 26% (12/47) for automated devices. Inaccurate BP measurement of only 3 mm Hg can have detrimental effects in the patient. This study shows a quarter of devices currently in use at a large teaching hospital to have an unacceptable calibration error. Regular maintenance and calibration checks are vital in ensuring that BP is measured as accurately as possible.
Introduction
Blood pressure (BP) measurement is one of the most commonly performed screening tests in clinical practice. Its accuracy is vital to the early diagnosis and effective management of hypertension, as emphasized by hypertension management guidelines. 1, 2 Concerns with regard to mercury toxicity and the recommendation of removing mercury sphygmomanometers from clinical practice 3 have resulted in a diverse range of aneroid and automated devices being developed and used to measure BP. In the UK alone, approximately 40 companies are actively involved in the supply of 90 different models of automated devices, of which the vast majority is oscillometric.
It is essential that these devices are validated according to a recognized protocol such as that of the British Hypertension Society (BHS) 4 or the International Protocol 5 of the European Society of Hypertension (ESH) before relying on them for clinical or home use. In addition, it is recommended that regular calibration assessments be carried out to ensure that devices conform to the European Standard specification 6 of having a leak rate within 4 mm Hg per min and a pressure scale accurate to within ± 3 mm Hg for any part of the pressure range. It is estimated that calibration errors could result in one in five hypertensive patients not being diagnosed and conversely almost one third of patients being wrongly diagnosed with hypertension. 7 A number of studies have shown poor calibration of aneroid sphygmomanometers, principally in primary care, [8] [9] [10] [11] [12] in which regular calibration assessments are not widely carried out. However, this error is greatly reduced if a proper maintenance protocol were implemented. 13 The errors rendering mercury sphygmomanometers inaccurate have also been documented, 14 but little is known about the calibration errors of automated devices in clinical practice.
The aim of the study was to identify which type of BP device is most subject to calibration errors in clinical use. We evaluated the leak rate and calibration accuracy of various BP devices (mercury, aneroid and automated) in use at St Thomas' Hospital, which currently has no service providing routine calibration assessments of non-invasive BP monitors.
Methods
All device assessments were made on site at St Thomas' Hospital (London, UK) over a 3-month period and followed the recommendations of the European Standard.
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Six diverse clinical areas were prospectively selected to ensure generalizability. These included the Hospital Birth Centre, Maternity High Dependency Unit, Surgical Recovery, Day Surgery Unit, Outpatient Departments (antenatal and medical) and various wards (gynaecology, ophthalmology, gastrointestinal, trauma orthopedics, plastic surgery, general medicine, stroke unit, neurology, geriatrics and vascular). All BP devices were assessed by the same member of the study team. Any device found to be in error by more than ± 3 mm Hg was removed from clinical use and replaced with a substitute calibrated device. In addition, it was noted whether these devices had been validated for clinical use according to a recognized protocol (BHS, Association for the Advancement of Medical Instrumentation (AAMI) and/or International Protocol), as listed on the BHS or the dableducational websites. 16, 17 An electronic pressure gauge (DPI 610, Druck UK Ltd, Leicester, UK) was used as the reference device. It had a digitization error of ± 0.005 mm Hg and an absolute pressure measurement uncertainty of ±0.2 mm Hg (at 95% confidence interval) over the range 0-500 mm Hg. The reference device/pressure gauge was calibrated at a United Kingdom Accreditation Service (UKAS) laboratory on commencement and completion of the study to ensure that pressure accuracy was maintained.
The cuff was wrapped around a 9 cm diameter rigid cylinder and connected to the reference device, a bulb and the test device using 'Y' connectors. Only one model of automated BP device (Dinamap Compact TS, GE Healthcare, Waukesha, WI, USA) required an airtight container to be used instead of a cuff and rigid cylinder, as recommended by the manufacturer. Each test device was subsequently set to 'calibration' mode according to the manufacturer's instructions to enable bypass of the electronic inflation and deflation functions of the device. Only one device (Dinamap Compact TS) required extra equipment for it to be set to the 'calibration' mode. The deflation valve of each device was then bypassed using a device-specific connector to connect the cuff tubing to the device. This allowed for manual inflation and deflation by the observer to pre-determined pressure points using an inflation bulb.
Leak rate assessment
During this assessment, the reference device measured the loss of pressure by the device over 1 min. After checking that all connections were tightly fitted and that the bulb was securely closed, the leak rate function of the reference device was selected and the cuff was manually inflated to 260 mm Hg. A 1-min countdown timer on the reference device was manually activated and this automatically recorded the starting pressure (0 s) and the resulting cuff pressure after 1 min, as well as the difference between the two. The difference had to be p4 mm Hg per min to fulfil the European Standard requirement.
Calibration accuracy assessment During this assessment, the reference device measured the static pressure in the test device relative to the atmosphere. After ensuring that the reference device was placed on a flat surface and that the bulb valve was open, the system pressure was zeroed using the reference device. The cuff was then manually inflated to 260 mm Hg and static pressures from the reference device were recorded at 250/200/ 150/100/50/0 mm Hg by pressing a button on the reference device at each respective pressure while manually controlling cuff deflation. To avoid bias, the digital display of the reference device was covered, blinding the observer to the reference pressures. All readings were stored in the reference device memory and downloaded to a computer after completion of the assessment.
The calibration assessment was carried out thrice to obtain a mean reference pressure that was compared with each spot pressure to determine the difference/calibration error at that specific pressure.
Analysis
Statistical analysis was conducted on all models with at least five devices using Stata v9 (Stata Corporation, College Station, TX, USA). A generalized linear model was fitted with an identity link using maximum likelihoods derived from the binomial distribution. Results are presented as differences of percentages rather than risk ratios or odds ratios because of the large number of values equal to 100%. Errors related to spot pressure are presented using box plots.
Readings obtained from both the test devices and the reference device was to the nearest 1 mm Hg. The small errors of rounding up a fraction of a mm Hg are assumed to be taken into account by the ± 3 mm Hg standard and were not adjusted for in analysis.
Results
A total of 128 BP devices were identified consisting of three types of devices: mercury (n ¼ 19), aneroid (n ¼ 62) and automated devices (n ¼ 47). In total, 22
Calibration accuracy of non-invasive blood pressure devices A de Greeff et al different models of devices were identified. Twelve of these were automated and only four had published evidence of validation according to a recognized protocol (BHS, AAMI or the International Protocol of the European Society of Hypertension). [18] [19] [20] [21] One mercury sphygmomanometer could not be tested because of an air leakage rate of 650 mm Hg per min, which was too great to permit a static pressure reading (in spite of the device being used in clinical practice).
There was no significant difference in the distribution of the leak rates between the three types of devices (P ¼ 0.36). However, only four devices achieved the European Standard specifies, which specifies a maximum allowed leak rate of 4 mm Hg per min. We defined a leak rate of 460 mm Hg per min as the threshold, above which the device would be considered to be in a poor condition, and this was found in the case of 6 mercury, 14 aneroid and 7 automated devices.
A box plot of leak rates for all types of BP devices assessed in the study is shown in Figure 1 . This presents the interquartile range, with the median leak rate indicated by the line in each box and outlying values represented by the circles. The grey horizontal line above 0 indicates the European Standard of a maximum leak rate of 4 mm Hg per min. Figure 2 , as the calibration error exceeded 15 mm Hg. The observed differences between errors generated by all the three types of devices were significant (aneroid/mercury difference of percentage: 8.3%, CI 5.4-11.3 and automated/mercury difference of percentage: 13.02%, CI 8.3-17.8).
The calibration drift of the reference device over the duration of the study was o0.5% according to the UKAS calibration assessment at the start and finish of the study. 18 whereas the majority (75%) of the Welch Allyn devices in use were the validated Spot Vital Signs model (Welch Allyn Inc.). 19, 20 Discussion A quarter of sampled BP devices tested at a tertiary care teaching hospital were found to have unacceptable calibration errors according to the European Standard specifications. We earlier found this to be true for 18% of the devices used in general practitioner (GP) surgeries. 11 The difference may be related to the greater variety of equipment included in this study and the more intense use of these devices in the hospital setting.
Make and model variation
Most surprisingly, the magnitude of errors in automated and aneroid devices was found to be similar. This is in contrast to our earlier study that Calibration accuracy of non-invasive blood pressure devices A de Greeff et al found the pressure scales of automated devices to be significantly more stable and accurate than those of aneroid devices, 11 although it only included devices from one manufacturer (Omron Co., Kyoto, Japan) and was conducted in the primary care setting. The sensor and pressure transducer of an automated device is said to have a limited lifespan and can be prone to losing calibration over time. This may be more evident in devices using a capacitance pressure transducer rather than a piezoelectric pressure transformer, which is reported to have a higher age stability. 22 However, to our knowledge no other Small over-and underestimations of pressure can have a substantial impact on diagnoses. It has been suggested that overestimation of systolic BP by as little as 3 mmHg increases the number of patients in a population classified as hypertensive by 24%. Equivalent underestimation causes 19% of the patients with systolic hypertension to be missed. 23 In aneroid devices, the calibration errors recorded over the pressure range seem equally divided between under-and over-recording, whereas automated devices (with the exception of one device) clearly under-record and mercury sphygmomanometers tend to over-record (Figure 2) .
Earlier studies assessing pressure scale accuracy of hospital devices have focused on aneroid devices and have yielded inconsistent results, 13, [24] [25] [26] which may be accounted for by different maintenance regimes for these devices once they enter clinical use.
The air leakage rate of a device provided useful information on the condition of the cuff, tubing, connections and release valve, as all of these were connected in parallel. Air leakage rates were worse in mercury devices than in aneroid or automated devices. Manual BP measurement is carried out with a deflation rate of 120-180 mm Hg per min and automated device deflation usually exceeds 180 mm Hg per min. As Korotkoff recognition during auscultation is more prone to deflation error than oscillometry, an increased air leakage rate will have a potentially dramatic effect on auscultatory/manual measurement accuracy compared with automated/ oscillometric devices. Nevertheless, we believe that an air leakage rate exceeding 60 mm Hg per min would constitute a device in poor condition, as the additional leakage may influence the accuracy of the measurement. The European standard of 4 mm Hg may therefore not be a clinically important standard to achieve, but it is a technical standard that is achievable and should be aimed for.
It is of some concern that only 4 of the 12 models identified in this study had published evidence of validation, despite the recommendation that only clinically validated devices be used to measure BP (a list of these devices is available on the BHS and dableducational websites). Evidence of clinical validation is imperative in ensuring that devices meet the required accuracy standard in the majority of patients. However, individual comparison measurements with an auscultatory standard may still be necessary in some individuals. Although very little comparative data is available for the performance of different makes of BP monitors and the sample size in this study is small, our results indicate that there may well be differences in the performance of different makes, which may warrant further investigation.
This study shows the importance of assessing the pressure scale of all BP measurement devices regularly once they enter clinical use. It remains important to procure only those devices that are clinically validated according to a recognized protocol. Calibration accuracy of non-invasive blood pressure devices A de Greeff et al
